Literature DB >> 21704883

Comparison of conventional and component-resolved diagnostics by two different methods (Advia-Centaur/Microarray-ISAC) in pollen allergy.

María Teresa Lizaso1, Blanca Esther García, Ana Isabel Tabar, Eva Lasa, Susana Echechipía, María José Alvarez, Marta Anda, Belén Gómez.   

Abstract

BACKGROUND: Component-resolved diagnostics (CRD) has recently been introduced into clinical allergology.
OBJECTIVE: The aim of this study was to assess the contribution that this new diagnostic technique makes to conventional diagnosis in patients with pollen allergy, comparing CRD with conventional technologies, and to compare 2 CRD methods, Advia-Centaur and Microarray-ISAC.
METHODS: Serum samples from 120 pollen-allergic patients were obtained. Immunoglobulin (Ig) E to total extracts (CAP System) and individual allergens using both CRD methods were determined.
RESULTS: The 3 diagnostic methods were in agreement in 62.5% of cases. In 30%, the CRD modified the conventional diagnosis either by detecting new relevant sensitizations (mainly to Olea) or by ruling out clinically irrelevant sensitizations caused by panallergens. The main differences between the 2 CRD methods were the deficiency in the ISAC version we used (ISAC-CRD-89) to detect sensitizations to Salsola and Plantago and that Advia-Centaur did not detect sensitizations to cypress. For all allergens except for Par j 1, a significant association in the frequency of sensitization was seen with the 2 CRD techniques and good agreement when comparing the results of the 2 methods in all cases. Significant correlation was found in the concentration of specific IgE in the 2 techniques for the most prevalent allergens in our setting. The results of the different profilins analyzed using Microarray-ISAC were superimposable although somewhat lower in the case of Phl p 12.
CONCLUSIONS: Component-resolved diagnostics modified the conventional diagnosis in 30% of cases. The results from the 2 CRD methods showed good agreement and correlation for most allergens.
Copyright © 2011 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704883     DOI: 10.1016/j.anai.2011.03.017

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  10 in total

1.  Evaluation of a novel automated allergy microarray platform compared with three other allergy test methods.

Authors:  P Williams; A Önell; F Baldracchini; V Hui; S Jolles; T El-Shanawany
Journal:  Clin Exp Immunol       Date:  2016-01-13       Impact factor: 4.330

Review 2.  Overview of component resolved diagnostics.

Authors:  Regina Treudler; Jan C Simon
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 3.  Variation in allergen content in sublingual allergen immunotherapy with house dust mites.

Authors:  F Moreno Benítez; M Espinazo Romeu; A Letrán Camacho; S Mas; F J García-Cózar; A I Tabar
Journal:  Allergy       Date:  2015-09-11       Impact factor: 13.146

4.  Precision medicine allergy immunoassay methods for assessing immunoglobulin E sensitization to aeroallergen molecules.

Authors:  Florin-Dan Popescu; Mariana Vieru
Journal:  World J Methodol       Date:  2018-11-29

5.  Sensitization profile in patients with respiratory allergic diseases: differences between conventional and molecular diagnosis (a cross-sectional study).

Authors:  Guillermo Til-Pérez; Claudio Carnevale; Pedro Luis Sarría-Echegaray; Diego Arancibia-Tagle; Sendy Chugo-Gordillo; Manuel David Tomás-Barberán
Journal:  Clin Mol Allergy       Date:  2019-05-02

6.  The use of the MeDALL-chip to assess IgE sensitization: a new diagnostic tool for allergic disease?

Authors:  Ingebjørg Skrindo; Christian Lupinek; Rudolf Valenta; Vegard Hovland; Sandra Pahr; Alexandra Baar; Kai-Håkon Carlsen; Petter Mowinckel; Magnus Wickman; Erik Melen; Jean Bousquet; Josep M Anto; Karin C Lødrup Carlsen
Journal:  Pediatr Allergy Immunol       Date:  2015-05       Impact factor: 6.377

7.  Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Authors:  Mustafa Cenk Ecevit; Müge Özcan; İlknur Haberal Can; Emel Çadallı Tatar; Serdar Özer; Erkan Esen; Doğan Atan; Sercan Göde; Çağdaş Elsürer; Aylin Eryılmaz; Berna Uslu Coşkun; Zahide Mine Yazıcı; Mehmet Emre Dinç; Fatih Özdoğan; Kıvanç Günhan; Nagihan Bilal; Arzu Yasemin Korkut; Fikret Kasapoğlu; Bilge Türk; Ela Araz Server; Özlem Önerci Çelebi; Tuğçe Şimşek; Rauf Oğuzhan Kum; Mustafa Kemal Adalı; Erdem Eren; Nesibe Gül Yüksel Aslıer; Tuba Bayındır; Aslı Çakır Çetin; Ayşe Enise Göker; Işıl Adadan Güvenç; Sabri Köseoğlu; Gül Soylu Özler; Ethem Şahin; Aslı Şahin Yılmaz; Ceren Güne; Gökçe Aksoy Yıldırım; Bülent Öca; Mehmet Durmuşoğlu; Yunus Kantekin; Süay Özmen; Gözde Orhan Kubat; Serap Köybaşı Şanal; Emine Elif Altuntaş; Adin Selçuk; Haşmet Yazıcı; Deniz Baklacı; Atılay Yaylacı; Deniz Hancı; Sedat Doğan; Vural Fidan; Kemal Uygur; Nesil Keleş; Cemal Cingi; Bülent Topuz; Salih Çanakçıoğlu; Metin Önerci
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-05

8.  Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children.

Authors:  Yvonne Resch; Sven Michel; Michael Kabesch; Christian Lupinek; Rudolf Valenta; Susanne Vrtala
Journal:  J Allergy Clin Immunol       Date:  2015-05-05       Impact factor: 10.793

9.  Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis.

Authors:  Johannes Huss-Marp; Jan Gutermuth; Ina Schäffner; Ulf Darsow; Florian Pfab; Knut Brockow; Johannes Ring; Heidrun Behrendt; Thilo Jakob; Christoph Ahlgrim
Journal:  Allergo J Int       Date:  2015-03-14

10.  A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics.

Authors:  Giorgio Walter Canonica; Ignacio J Ansotegui; Ruby Pawankar; Peter Schmid-Grendelmeier; Marianne van Hage; Carlos E Baena-Cagnani; Giovanni Melioli; Carlos Nunes; Giovanni Passalacqua; Lanny Rosenwasser; Hugh Sampson; Joaquin Sastre; Jean Bousquet; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2013-10-03       Impact factor: 4.084

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.